Critics believe Donald Trump's nominee to lead Health and Human Services poses a threat to the achievements of a ...
FDA Chief Robert Califf reflects on potential changes as Trump's re-election looms, expressing disappointment and ...
The U.S. Food and Drug Administration on Friday approved Syndax Pharmaceuticals' drug for the treatment of adult and ...
BioNTech said that it is acquiring the Chinese drugmaker Biotheus for $800 million to bolster its cancer strategy. The two ...
Surging demand for a new generation of highly effective anti-obesity medications is creating interest in compounded versions of these medications.
Should Kennedy win Senate confirmation, his critics say he is threatening the achievements of a science-based public health ...
The FDA spent more than 15 years crafting the guidelines, which are designed to do away with industry practices that downplay ...
Food and Drug Administration commissioner Robert Califf said he was “disappointed” with the presidential election result and ...